These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20803352)

  • 21. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
    Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
    Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
    Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
    Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
    Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
    Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
    Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
    J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical Significance of Detecting CD4
    Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular lymphoma: 2020 update on diagnosis and management.
    Freedman A; Jacobsen E
    Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphomas.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):248-61. PubMed ID: 18359244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
    Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
    Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
    Boughan KM; Caimi PF
    Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical applicability of current prognostic models in follicular lymphoma: A systematic review.
    Jelicic J; Stauffer Larsen T; Bukumiric Z; Andjelic B
    Crit Rev Oncol Hematol; 2021 Aug; 164():103418. PubMed ID: 34246773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
    Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
    Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
    Lockmer S; Ren W; Brodtkorb M; Østenstad B; Wahlin BE; Pan-Hammarström Q; Kimby E
    Br J Haematol; 2020 Jan; 188(2):259-267. PubMed ID: 31423576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.
    Milcent B; Josseaume N; Petitprez F; Riller Q; Amorim S; Loiseau P; Toubert A; Brice P; Thieblemont C; Teillaud JL; Sibéril S
    Sci Rep; 2019 Sep; 9(1):13471. PubMed ID: 31530876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of prognostic indices in patients with follicular lymphomas.
    Radojkovic M; Ristic S; Colovic M; Mihaljevic B; Cemerikic-Martinovic V
    Med Oncol; 2006; 23(4):533-42. PubMed ID: 17303912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.